# FDA 483 - I.G. Raak - November 17, 2022

Source: https://www.globalkeysolutions.net/records/483/ig-raak/738fa9bc-df0a-4380-9948-afde038105c0

> FDA 483 for I.G. Raak on November 17, 2022. Product: veterinary. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: I.G. Raak
- Inspection Date: 2022-11-17
- Product Type: veterinary
- Office Name: Minneapolis District Office
- Summary: An FDA inspection of I.G. Raak in Jasper, MN, revealed two significant observations related to animal drug use. The firm offered a food-producing animal for interstate commerce with an unapproved drug residue (ciprofloxacin) in edible tissue. Additionally, the firm administered animal drugs contrary to label directions and without a valid veterinary/client/patient relationship, specifically regarding flunixin meglumine and penicillin.

## Related Documents

- [483 - 2023-12-06](https://www.globalkeysolutions.net/records/483/ig-raak/a982fdb4-9491-408a-895d-96fbca8104e7)

## Related Officers

- [Investigator](https://www.globalkeysolutions.net/people/robert-j-waldorf/e8ef9c41-f6e4-4815-af0c-b2b4e04488b2)

Company: https://www.globalkeysolutions.net/companies/ig-raak/8d4b36c8-652c-4142-b652-5b2f7bb40872

Office: https://www.globalkeysolutions.net/offices/minneapolis-district-office/c79fc8dc-f884-48fc-ba80-2947f662511d